Receptors for 1,25-dihydroxyvitamin D3 in gynecologic neoplasms
- 18 February 1992
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 44 (2), 131-136
- https://doi.org/10.1016/0090-8258(92)90028-h
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Therapeutic effects of low‐dose cytosine arabinoside, alpha‐interferon, 1α‐hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromesEuropean Journal of Haematology, 1988
- The use of a human endometrial carcinoma cell line (RL-95) for testing of chemotherapeutic agentsGynecologic Oncology, 1987
- Carcinogenesis: A superfamily of potentially oncogenic hormone receptorsNature, 1986
- Vitamin D Receptors: Nature and FunctionAnnual Review of Nutrition, 1986
- Newly discovered activities for calcitriol (1,25‐dihydroxyvitamin D3): Implications for future pharmacological useBioEssays, 1986
- 1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor.Journal of Clinical Investigation, 1984
- Prognostic factors in primary breast cancerBreast Cancer Research and Treatment, 1983
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- 1,25-DIHYDROXYVITAMIN-D RECEPTOR IN BREAST CANCER CELLSThe Lancet, 1979
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949